for anyone interested in this stock, this is worth listening to as it outlines many of their timelines. Trial completion expected next month, FDA submission early 2018. He also outlines their marketing setup and existing distribution channels. This is a no brainer at the moment and if not for the CR this would be 40 cents. This product may go viral after final results are released as it addresses a huge unmet need in the field of autism.
Ann: Investor Call, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
